298380 — ABL Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for ABL Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	133,288	70,391	43,647	78,309	71,150
Net Total Accounts Receivable
Net Total Receivables	755	1,394	208	573	2,003
Prepaid Expenses
Total Other Current Assets
Total Current Assets	134,657	71,920	45,472	80,535	75,539
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,042	4,065	3,304	6,713	76,035
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	142,903	99,894	65,453	185,181	160,144
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,327	7,969	8,750	72,172	41,760
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	10,895	9,230	9,500	115,667	86,065
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	132,008	90,665	55,953	69,513	74,079
Total Liabilities & Shareholders' Equity	142,903	99,894	65,453	185,181	160,144
Total Common Shares Outstanding